Answers are grounded in this paper and cite their sources.
This review provides an overview of the epidemiology, evolution of therapies, and future challenges of heart failure in Asia.
Heart failure (HF) is the final pathway of multiple cardiac diseases. It exerts its clinical burden globally. In this brief review, its epidemiology in Asia is described, followed by an overview of the evolution of past therapies to present strategies available in Asia, and finally, future challenges are identified.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: